UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial

Translational psychiatry, 2021-06, Vol.11 (1), p.355-355, Article 355

2021

Volltextzugriff (PDF)

Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder

Neuropsychopharmacology (New York, N.Y.), 2021-02, Vol.46 (3), p.519-527

2021

Volltextzugriff (PDF)

Reward, Relief and Habit Drinking: Initial Validation of a Brief Assessment Tool

Alcohol and alcoholism (Oxford), 2019-12, Vol.54 (6), p.574-583

2019

Volltextzugriff (PDF)

The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study

Neuropsychopharmacology (New York, N.Y.), 2015-09, Vol.40 (10), p.2347-2356

2015

Volltextzugriff (PDF)

Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol

Pharmacology, biochemistry and behavior, 2012-12, Vol.103 (2), p.253-259

2012

Volltextzugriff (PDF)

State-of-the-art behavioral and pharmacological treatments for alcohol use disorder

The American journal of drug and alcohol abuse, 2019-03, Vol.45 (2), p.124-140

2019

Volltextzugriff (PDF)

Convergence between the Penn Alcohol Craving Scale and diagnostic interview for the assessment of alcohol craving

Addictive behaviors reports, 2019-12, Vol.10, p.100198-100198, Article 100198

2019

Volltextzugriff (PDF)

Sensitivity and specificity of a commercial urinary ethyl glucuronide (ETG) test in heavy drinkers

Addictive behaviors reports, 2020-06, Vol.11, p.100249-100249, Article 100249

2020

Volltextzugriff (PDF)

Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial

Neuropsychopharmacology (New York, N.Y.), 2017-08, Vol.42 (9), p.1776-1788

2017

Volltextzugriff (PDF)

Experimental psychopathology paradigms for alcohol use disorders: Applications for translational research

Behaviour research and therapy, 2016-11, Vol.86, p.11-22

2016

Volltextzugriff (PDF)

Subjective Response to Alcohol as a Research Domain Criterion

Alcoholism, clinical and experimental research, 2016-01, Vol.40 (1), p.6-17

2016

Volltextzugriff (PDF)

Understanding Naltrexone Mechanism of Action and Pharmacogenetics in Asian Americans via Behavioral Economics: A Preliminary Study

Experimental and clinical psychopharmacology, 2012-06, Vol.20 (3), p.181-190

2012

Volltextzugriff (PDF)

The Effects of Drinking Goal on Treatment Outcome for Alcoholism

Journal of consulting and clinical psychology, 2013-02, Vol.81 (1), p.13-22

2013

Volltextzugriff (PDF)

Lifetime heavy drinking years predict alcohol use disorder severity over and above current alcohol use

The American journal of drug and alcohol abuse, 2021-09, Vol.47 (5), p.630-637

2021

Volltextzugriff (PDF)

A meta-regression of methodological features predicting the effects of pharmacotherapies on subjective response to alcohol

Alcoholism, clinical and experimental research, 2021-07, Vol.45 (7), p.1336-1347

2021

Volltextzugriff (PDF)

Response to Letter to the Editors regarding ‘A Meta-Regression of Trial Features Predicting the Effects of Alcohol Use Disorder Pharmacotherapies on Drinking Outcomes in Randomized Clinical Trials: A Secondary Data Analysis’

Alcohol and alcoholism (Oxford), 2023-11, Vol.58 (6), p.690-691

2023

Volltextzugriff (PDF)

Differences in the subjective and motivational properties of alcohol across alcohol use severity: application of a novel translational human laboratory paradigm

Neuropsychopharmacology (New York, N.Y.), 2018-08, Vol.43 (9), p.1891-1899

2018

Volltextzugriff (PDF)

Capturing habitualness of drinking and smoking behavior in humans

Drug and alcohol dependence, 2020-02, Vol.207, p.107738-107738, Article 107738

2020

Volltextzugriff (PDF)

Pharmacogenetics of Naltrexone in Asian Americans: A Randomized Placebo-Controlled Laboratory Study

Neuropsychopharmacology (New York, N.Y.), 2012-01, Vol.37 (2), p.445-455

2012

Volltextzugriff (PDF)

The Interplay Between Subjective Response to Alcohol, Craving, and Alcohol Self‐Administration in the Human Laboratory

Alcoholism, clinical and experimental research, 2019-05, Vol.43 (5), p.907-915

2019

Volltextzugriff (PDF)

Mechanisms of topiramate effects: how and for whom does it work?

Addiction biology, 2015-06

2015

Volltextzugriff (PDF)

Functional significance of subjective response to alcohol across levels of alcohol exposure

Addiction biology, 2017-01, Vol.22 (1), p.235-245

2017

Volltextzugriff (PDF)

Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter?

The American journal of drug and alcohol abuse, 2017-11, Vol.43 (6), p.703-710

2017

Volltextzugriff (PDF)

Modeling motivation for alcohol in humans using traditional and machine learning approaches

Addiction biology, 2021-05, Vol.26 (3), p.e12949-n/a

2021

Volltextzugriff (PDF)

A Meta-Regression of Trial Features Predicting the Effects of Alcohol Use Disorder Pharmacotherapies on Drinking Outcomes in Randomized Clinical Trials: A Secondary Data Analysis

Alcohol and alcoholism (Oxford), 2022-09, Vol.57 (5), p.589-594

2022

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(51)
Dissertationen
(1)

Sprache

Englisch
(52)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial

Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder

Reward, Relief and Habit Drinking: Initial Validation of a Brief Assessment Tool

The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study

Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol

State-of-the-art behavioral and pharmacological treatments for alcohol use disorder

Convergence between the Penn Alcohol Craving Scale and diagnostic interview for the assessment of alcohol craving

Sensitivity and specificity of a commercial urinary ethyl glucuronide (ETG) test in heavy drinkers

Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial

Experimental psychopathology paradigms for alcohol use disorders: Applications for translational research

Subjective Response to Alcohol as a Research Domain Criterion

Understanding Naltrexone Mechanism of Action and Pharmacogenetics in Asian Americans via Behavioral Economics: A Preliminary Study

The Effects of Drinking Goal on Treatment Outcome for Alcoholism

Lifetime heavy drinking years predict alcohol use disorder severity over and above current alcohol use

A meta-regression of methodological features predicting the effects of pharmacotherapies on subjective response to alcohol

Response to Letter to the Editors regarding ‘A Meta-Regression of Trial Features Predicting the Effects of Alcohol Use Disorder Pharmacotherapies on Drinking Outcomes in Randomized Clinical Trials: A Secondary Data Analysis’

Differences in the subjective and motivational properties of alcohol across alcohol use severity: application of a novel translational human laboratory paradigm

Capturing habitualness of drinking and smoking behavior in humans

Pharmacogenetics of Naltrexone in Asian Americans: A Randomized Placebo-Controlled Laboratory Study

The Interplay Between Subjective Response to Alcohol, Craving, and Alcohol Self‐Administration in the Human Laboratory

Mechanisms of topiramate effects: how and for whom does it work?

Functional significance of subjective response to alcohol across levels of alcohol exposure

Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter?

Modeling motivation for alcohol in humans using traditional and machine learning approaches

A Meta-Regression of Trial Features Predicting the Effects of Alcohol Use Disorder Pharmacotherapies on Drinking Outcomes in Randomized Clinical Trials: A Secondary Data Analysis

Suchergebnisse filtern